CardioBrief

One-stop source for cardiology news and links

Main menu

Skip to content
  • Home
  • About
  • CardioBrief Rebel Mouse
    • The Controversy Over The TACT Chelation Trial

Tag Archives: american heart

November 3, 2012

AHA 2012: Welcome to LA Reply

by Larry Husten • Uncategorized • Tags: american heart

The American Heart Assocation meeting gets going tomorrow. Overall the trend is toward smaller US meetings, but someone didn’t tell that to the sign department:

And there’s something fishy on the buses:

 

About these ads

Post navigation

Note to Readers: A Time For Change

Click here to read about important new changes to CardioBrief.

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 6,479 other followers

Follow CardioBrief via Twitter

Follow @cardiobrief

Follow CardioBrief VIA RSS

RSS Feed RSS - Posts

CardioBrief Tweets

  • RT @EJSMD: Gorgeous and creative site for promotion of healthy food choices for kids from @doctorwes daughter bit.ly/10jk0vx <worth… 15 hours ago
  • Unknown Mathematician Proves Elusive Property of Prime Numbers | Wired Science | Wired.com wired.com/wiredscience/2… 19 hours ago
  • RT @CardioEx: Selections from Richard Lehman’s Literature Review: May 20th... bit.ly/14oJNG0 1 day ago
  • @rafadiazmd Thanks! I've been using Preview for ages and should have known this!!! #iamadumbass 1 day ago
  • Anyone know of an easy-to-use PDF reader that allows simple highlighting and note taking? and perhaps free? #dumbquestion 1 day ago
  • RT @eyeonfda: 24 hours till my Webinar tomorrow at 12 Noon ET Comparing FDA Enforcement Digital v/ Non-Digital Media - http://t.co/tjMsQMFS… 1 day ago
  • ICYMI: Instagram for Heart Attacks: iPhone App Speeds ECG Transmission To Hospital wp.me/ppMHd-3Hb 1 day ago
  • RT @MRCCTU: Today is International Clinical Trials Day, which commemorates the day James Lind started his famous trial on scurvy: http://t.… 1 day ago
  • John Fauber on a $307k/yr drug and "where to draw the line between a charity and a… publicly traded drug company" jsonline.com/watchdog/watch… 2 days ago
  • MT @Jonathan__Leake: Multiverse: ...Scientists claim 1st hard evidence for other universes. thesundaytimes.co.uk/sto/news/uk_ne… >hardly "hard"! 2 days ago
  • RT @Toaster_Pastry: HEART NEWS: Dronedarone vs. Placebo for a-fib saved money on hospitalizations. Drug still overpriced crap. http://t.co/… 2 days ago
  • RT @drrwinters: Looking forward to some powerful one-on-one conversations this week. Instead of saying: “I agree.” I’m going to start sayin… 2 days ago
  • @adamfeuerstein even non Trekkies like me know it's K... 3 days ago
  • I had a random lunch encounter with Mommy bloggers: thelilmamas.com yfrog.com/g0rb4yfj 4 days ago
  • RT @adamfeuerstein: $AMRN - No Vascepa NCE decision... again. 4 days ago
  • Thoratec wins FDA nod for HeartMate controller - FierceMedicalDevices: fiercemedicaldevices.com/story/thoratec… 4 days ago
Follow @cardiobrief

CardioBrief Classics

Coca-Cola, The Olympic Torch, And The American College Of Cardiology
Stem Cell Therapy Company Hypes Preliminary Results
Good Science/Bad Science: Contrasting Papers On Dietary Compositon In JAMA And BMJ
Subway Meals Get American Heart Association Endorsement
This Week In Medicine: Stop Exercising and Eat Chocolate!
You Know Nothing, Dr. Snow: Why Medicine Can’t Be More Like Facebook
Politics and Transcatheter Aortic Valve Replacement
Half the News That’s Fit To Print: NY Times On ECG Screening For Student Athletes
New Perspective on the Dutch Cardiovascular Research Scandal
Mark Midei Can’t Get a Job Taking Blood Pressure At A Walmart
And the 2012 Award For the Most Dumbass Drug Promotion Goes To…
You Know Nothing, Dr. Snow: Why Medicine Can’t Be More Like Facebook
Politics and Transcatheter Aortic Valve Replacement
Half the News That’s Fit To Print: NY Times On ECG Screening For Student Athletes
Mark Midei Can’t Get a Job Taking Blood Pressure At A Walmart
Guest Post: More Lessons From the Riata ICD Lead Recall
Japanese Researcher With Harvard Connections Retracts 3 Articles in AHA Journals
Lancet Editor Richard Horton Tweets Dark View of Contemporary Medicine
Resveratrol and Fraud
Director of UConn CV Research Center Accused of Scientific Misconduct
2011 in Review: Rivaroxaban, Sapien, Mark Midei, Conflicts of Interest, and Much More
Nissen and Topol Clash Over Genetics and Personalized Medicine
Ray of Light for the Physician Payment Sunshine Act
Letter From Jail: A Cautionary Tale
One More Thought About Lipitor
Experts Clash Over Interpretation and Value of AIM-HIGH
Controversy Over Cholesterol Testing for Children
CardioBrief Poll: Should the ACC Train Industry Reps?
Daily Show Asks Why the AHA Killed a Bill Encouraging Healthy Behavior
National Lipid Association Expert Panel Has Many Deep Ties To Industry
Industry & Medicine: It’s Complicated
Easy Come, Easy Go? ESC To Review Dronedarone’s Role in AF Guidelines
The Pen Is Mightier Than the Scold
CNN Documentary Promises Screening and Vegan Diet Can Eliminate Heart Attacks
CNN, ABC, and NBC Dumb Down the News About CV Screening
US Senate Unanimously Endorses Campaign Against Atrial Fibrillation
Less May Be More, But Stents Are Neither Good Nor Bad
The Voice of the Patient: Time To Bring Out the Muzzle?
New Concerns Raised About Withdrawn Archives Meditation Paper
Archives Decides At Last Minute Not to Publish a Scheduled Paper
Part 2: The National Lipid Association And Industry
Part 1: The National Lipid Association and the FH Guidelines
Understanding Risk: Tricky Business
ACC CEO Jack Lewin Provides The Argument Against Industry Money
The ACC Counts Down To Launch Of New Satellites
Scientific Fraud Found In Wayne Alexander’s Research Group At Emory
$50K: The Price For A VIP Dinner For 2 With The Cleveland Clinic CEO
Evidence: The Weak Link Of Evidence-Based Medicine
Taking Medical Advice From Peggy Fleming?
The ACC Wants You To Know That Nothing Is Rotten In The State Of Maryland
An Embargo Becomes A Public Relations Tool
PROTECT II: Who Will Protect Us From The Protectors?
GRAVITAS Published: Who Gets To Weigh In On the Results?
WebMD: the 800 Pound Gorilla in the Room
Some Things Don’t Go Better With Coke
ACC and HRS Downplay Data From Their Own Registry
Dangling Doctors In Front of Journalists
Spinning Out of Control: Another Look at the PROTECT II Press Release
Questions Raised About Compensation and Conflicts at Duke
SHARP: A Tale of Two Press Releases
Will This Be the HDL Decade? REVEAL Revealed, Mixed Results for Apo-A1
CardioExchange at the AHA: A New Voice Emerges
Top New York City Interventional Cardiologists Now Making $3 Million a Year
The Plot Thickens in the Case of the Exploding ICD
Red light or green light for AAA screening?
Blue light special: AAA screening at Kmart in the disease-mongering aisle
The rise of the ESC: is the ESC anti-American or pro-industry?
Dronedarone and ticagrelor speed into ESC guidelines
The debate over CME and industry influence continues
Avandia aftermath: who are the winners and losers?
Debating medical promotion and education
Why is there a red dress on diet Coke cans?
SHAPE shifting: transforming guidelines into a business venture
Why was an Abbott marketing study published in the American Journal of Cardiology?
At the Dallas valve meeting even the faculty is for sale
A missing piece of the Multaq puzzle finally appears: DIONYSOS published to little fanfare
EHJ editors rebuffed GSK efforts to suppress Nissen editorial on rosiglitazone
“Is it safe?”
Why we shouldn’t kill all the lawyers just yet
Why is there a red dress on diet Coke cans?
Sunday at the AHA: ARBITER’s wild roller coaster ride in Orlando
Cardiology $$$: Mt Sinai’s Samin Sharma tops Columbia’s Moses
Residual Risk Reduction Initiative: promotion or education?
Editorial: the incompetence of the FDA
Editorial: SHAPE is skating on thin ice
Extreme cardiology culture: Califf, Harrington, Topol & Teirstein
October thought experiment: suppose the World Series were covered like the Nobel Prize
Live AF ablation broadcast on Today Show: what’s wrong with this picture?
More Multaq: Prystowsky whack-a-mole, ACC responds, Sanofi overtures to EPs
Pieces of a puzzle: Multaq, Sanofi, ACC, HRS, Prystowsky, AF Guidelines

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 6,479 other followers

Follow on Twitter

Follow @cardiobrief
My Google Plus Profile
Site Meter

  • Edward J. Schloss MD
  • Larry Husten

Top Posts

  • Athletes With Defibrillators Don't Need To Quit Sports
  • European Medicines Agency Starts Review of Combined Use Of Drugs That Block The Renin-Angiotensin System
  • Similar Cardiovascular Risk Observed With COPD Drugs
  • Phentermine/Topiramate Combination Yields Significant Weight Loss
  • Instagram for Heart Attacks: iPhone App Speeds ECG Transmission To Hospital
  • AHA/ACC release thoracic aortic disease guidelines
  • Novel Leadless Pacemaker Makes Debut At HRS 2013
  • Anticoagulation Update: New Agent For Urgent Anticoagulation Reversal, Pradaxa Label Revised
  • About
  • Cardiology $$$: Mt Sinai's Samin Sharma tops Columbia's Moses
  • Heart Failure Death Statistics: Don’t believe what you read on the internet
  • Top New York City Interventional Cardiologists Now Making $3 Million a Year

Archives

  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009

Meta

  • Register
  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.com

Enter your email address to subscribe to CardioBrief and receive notifications of new posts by email.

Join 6,479 other followers

Follow on Twitter

Follow @cardiobrief

RSS Feed RSS - Posts

Archives

Recent Comments

Cardiology EP Doc on Heart Rhythm Society Advising…
eduardo on Resveratrol and Fraud
HEPARIN BASED T1 TRE… on Bruise Control: Continued Warf…
Larry Husten on Our Limitless Capacity For…
Alan Averson on Our Limitless Capacity For…

Meta

  • Register
  • Log in
  • Entries RSS
  • Comments RSS
  • Blog at WordPress.com.
Blog at WordPress.com. | Theme: Newsy by Automattic. Design by Themify.
Follow

Get every new post delivered to your Inbox.

Join 6,479 other followers

Powered by WordPress.com